These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3967085)

  • 1. The role of activated human platelets in prothrombin and factor X activation.
    Rosing J; van Rijn JL; Bevers EM; van Dieijen G; Comfurius P; Zwaal RF
    Blood; 1985 Feb; 65(2):319-32. PubMed ID: 3967085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in membrane phospholipid distribution during platelet activation.
    Bevers EM; Comfurius P; Zwaal RF
    Biochim Biophys Acta; 1983 Dec; 736(1):57-66. PubMed ID: 6418205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet procoagulant properties studied with snake venom prothrombin activators.
    Speijer H; Govers-Riemslag JW; Zwaal RF; Rosing J
    Thromb Haemost; 1987 Jun; 57(3):349-55. PubMed ID: 3310319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of procoagulant binding sites on the platelet surface.
    Bevers EM; Rosing J; Zwaal RF
    Adv Exp Med Biol; 1985; 192():359-71. PubMed ID: 3914834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen derived octapeptide inhibits platelet procoagulant activity induced by the combined action of collagen and thrombin.
    Bevers EM; Karniguian A; Legrand YJ; Zwaal RF
    Thromb Res; 1985 Feb; 37(3):365-70. PubMed ID: 3922080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder.
    Rosing J; Bevers EM; Comfurius P; Hemker HC; van Dieijen G; Weiss HJ; Zwaal RF
    Blood; 1985 Jun; 65(6):1557-61. PubMed ID: 3995186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets.
    Briedé JJ; Tans G; Willems GM; Hemker HC; Lindhout T
    J Biol Chem; 2001 Mar; 276(10):7164-8. PubMed ID: 11113137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.
    Tans G; Rosing J; Thomassen MC; Heeb MJ; Zwaal RF; Griffin JH
    Blood; 1991 Jun; 77(12):2641-8. PubMed ID: 2043766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet procoagulant complex assembly in a tissue factor-initiated system.
    Monroe DM; Roberts HR; Hoffman M
    Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of human blood platelets in prothrombin and in factor X activation induced by ionophore A23187.
    van Rijn J; Rosing J; van Dieijen G
    Eur J Biochem; 1983 Jun; 133(1):1-10. PubMed ID: 6406226
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane-skeleton in the regulation of membrane lipid asymmetry?
    Verhallen PF; Bevers EM; Comfurius P; Zwaal RF
    Biochim Biophys Acta; 1987 Sep; 903(1):206-17. PubMed ID: 2820487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of aggregation and release on platelet prothrombin-converting activity.
    Cox AC; Inyangetor P; Esmon CT; White BN
    Blood; 1979 Sep; 54(3):659-72. PubMed ID: 465734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane phospholipids are the major determinant of the binding site for factor X activating--and prothrombinase complexes at the surface of human platelets.
    Bevers EM; Rosing J; Zwaal RF
    Agents Actions Suppl; 1986; 20():69-75. PubMed ID: 3468783
    [No Abstract]   [Full Text] [Related]  

  • 14. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations.
    Tracy PB; Eide LL; Mann KG
    J Biol Chem; 1985 Feb; 260(4):2119-24. PubMed ID: 3972783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet membrane involvement in blood coagulation.
    Hemker HC; van Rijn JL; Rosing J; van Dieijen G; Bevers EM; Zwaal RF
    Blood Cells; 1983; 9(2):303-17. PubMed ID: 6661560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X.
    Neuenschwander P; Jesty J
    Blood; 1988 Nov; 72(5):1761-70. PubMed ID: 3140913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced prothrombin-converting activity and factor Xa binding of platelets activated by the alternative complement pathway.
    Ozge-Anwar AH; Freedman JJ; Senyi AF; Cerskus AL; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):221-8. PubMed ID: 6610438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of coagulation factor X activation by platelet-bound factor IXa.
    Rawala-Sheikh R; Ahmad SS; Ashby B; Walsh PN
    Biochemistry; 1990 Mar; 29(10):2606-11. PubMed ID: 2110473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anticoagulant effect of the human secretory phospholipase A2 on blood plasma and on a cell-free system is due to a phospholipid-independent mechanism of action involving the inhibition of factor Va.
    Mounier C; Franken PA; Verheij HM; Bon C
    Eur J Biochem; 1996 May; 237(3):778-85. PubMed ID: 8647125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.